8,517 articles
Anat Stemmer‐Rachamimov
Anat Stemmer-Rachamimov, also published as Anat O. Stemmer-Rachamimov, is a neuropathologist and Associate Professor of Pathology at Harvard Medical School and Massachusetts General Hospital, known for research on neurofibromatosis.
Anath Shalev
Anath Shalev, MD, is an endocrinologist and diabetes researcher who directs the UAB Comprehensive Diabetes Center and led the 2018 verapamil trial in type 1 diabetes.
Anatole Chauffard
Anatole Chauffard (1855–1932) was a French internist and professor of clinical medicine at the Faculté de médecine de Paris, known for work on hemolytic jaundice and the eponyms Minkowski-Chauffard disease and Troisier-Hanot-Chauffard syndrome.
Ancel Keys
Ancel Keys (1904–2004), American University of Minnesota physiologist, K-ration designer, Minnesota Starvation Experiment leader, and proposer of the diet-heart hypothesis and Seven Countries Study linking saturated fat to heart disease.
Anders A. F. Sima
Anders A. F. Sima is a Swedish-trained neuropathologist known for research on diabetic neuropathy and the polyol pathway, and a professor at Wayne State University.
Anders Ekbom
Anders Ekbom (1947–2024) was a Swedish clinical epidemiologist and former surgeon, professor of epidemiology at Karolinska Institutet, known for register-based studies of cancer risk in inflammatory bowel disease.
Anders Hamsten
Anders Hamsten is a Swedish physician-scientist at Karolinska Institutet who showed in the 1980s that high PAI-1 levels raise heart attack risk in young survivors.
Anders Hviid
Anders Peter Hviid is a Danish epidemiologist and professor at Statens Serum Institut in Copenhagen, known for large register-based studies of MMR vaccination and autism and pregnancy safety of HPV vaccination.
Anders M. Dale
Anders M. Dale is an American neuroscientist who co-developed the FreeSurfer brain-imaging software, led the ABCD Study's data center, and became president of the J. Craig Venter Institute in 2025.
Anders Perner
Anders Perner is a Danish intensive care specialist and professor at the University of Copenhagen who led landmark Scandinavian trials on fluids and transfusion in septic shock.
Anderson Gray McKendrick
Anderson Gray McKendrick (1876–1943) was a Scottish physician and epidemiologist who, with William Ogilvy Kermack, published the 1927 epidemic theory paper introducing the threshold theorem.
André Bazex
André Bazex (1911–1988) was a French dermatologist and professor of dermatology at the University of Toulouse, known for two eponymous syndromes he described in the 1960s.
André De Léan
André De Léan is a pharmacology researcher who was first author of the 1980 ternary complex model of G-protein-coupled receptor activation, credited in Lefkowitz's 2012 Nobel Prize.
André Gratia
André Gratia (1893–1950) was a Belgian microbiologist, professor at the University of Liège, who isolated the first staphylococcal bacteriophage in 1921 and discovered colicins, the first known bacteriocins, in 1925.
André Lacroix (Canadian endocrinologist)
André Lacroix is a Canadian endocrinologist and physician-scientist at CHUM and the Université de Montréal, known for describing food-dependent Cushing's syndrome in a 1992 New England Journal of Medicine paper.
André Lamy
André Lamy is a cardiac surgeon at Hamilton Health Sciences and professor at McMaster University, known for leading the CORONARY trial of off-pump versus on-pump bypass surgery.
André Lemierre
André-Alfred Lemierre (1875–1956) was a French bacteriologist and professor of microbiology at the Hospital Claude Bernard in Paris, remembered for his 1936 description of Lemierre's syndrome.
André Léri
André Léri (1875–1930) was a French neurologist of the Paris school, a pupil of Joseph Babinski and Pierre Marie, known for Léri's sign, Léri pleonosteosis, and Léri-Weill dyschondrosteosis.
André Marette
André Marette is a full professor at Université Laval in Quebec City and researcher at the Quebec Heart and Lung Institute, known for work on insulin resistance and diabetes.
André Terzic
André Terzic is a physician-scientist at Mayo Clinic in Rochester, Minnesota, who led its regenerative medicine center and linked KATP channel genes to heart disease.
Andrea Alimonti
Andrea Alimonti (born 1975, Mendrisio, Switzerland) is an oncologist who directs the Institute of Oncology Research in Bellinzona, known for discovering PTEN-loss-induced cellular senescence in cancer.
Andrea Califano
Andrea Califano is a systems biologist at Columbia University known for the ARACNe and VIPER algorithms and for master regulator proteins in cancer; he now leads Chan Zuckerberg Biohub New York.
Andrea Cercek
Andrea Cercek is a medical oncologist specializing in gastrointestinal cancers who leads colorectal cancer research and treatment at Memorial Sloan Kettering Cancer Center in New York.
Andrea Cipriani
Andrea Cipriani is an Italian psychiatrist and Professor of Psychiatry at Oxford whose large-scale network meta-analyses of antidepressants, published in The Lancet, inform clinical guidelines.
Andrea Crisanti
Andrea Crisanti is an Italian molecular parasitologist at the University of Padua known for building gene drives that spread through malaria mosquito populations, and a senator in the Italian Parliament.
Andrea K. Ng
Andrea K. Ng, also known as Andrea Ng, is an American radiation oncologist at Dana-Farber and Harvard known for research on late effects of Hodgkin lymphoma treatment.
Andrea Lisco
Andrea Lisco is an Italian-trained physician-scientist and viral immunologist who leads a research unit at NIAID in Bethesda, Maryland, studying HPV-related disease in immunodeficiencies and becoming a Lasker Clinical Research Scholar in 2024.
Andrea Necchi
Andrea Necchi is an Italian medical oncologist directing genitourinary medical oncology at IRCCS Ospedale San Raffaele in Milan, known for leading the PURE-01 trial of pembrolizumab before bladder cancer surgery.
Andrea Schietinger
Andrea Schietinger is a cancer immunologist who leads a laboratory at Memorial Sloan Kettering Cancer Center, known for work on T cell dysfunction in cancer.
Andrea van Elsas
Andrea van Elsas is a tumor immunology researcher, first author of a 1999 melanoma study cited by the Nobel Assembly as key background for the 2018 Nobel Prize.